Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study. - Tsimikas S; Viney NJ; Hughes SG; Singleton W; Graham MJ; Baker BF; Burkey JL; Yang Q; Marcovina SM; Geary RS; Crooke RM; Witztum JL (Lancet (London, England), 2015)